Physician
Asthma & Allergy Center LLC
Asthma & Allergy Center LLC was paid $11.48M by Medicaid between Jan 2018 and Dec 2024, across 32 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 29% of everything it billed.
33Billing provider infoASTHMA & ALLERGY CENTER LLC
ROCKVILLE, MD 20850
ROCKVILLE, MD 20850
33aNPI1912089335assigned 10/19/2006
33bProvider typeAllergy & Immunology Physician
28Total paid$11.48M
24GClaims217,543
24DCodes billed32
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy & Immunology Physician providers in Maryland
Rank by total paid#1 of 18
Median peer was paid$171K
This provider vs. median67×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 598 | $6K | |
| 2019 | 1,473 | $8K | |
| 2020 | 27,202 | $1.08M | |
| 2021 | 35,747 | $2.00M | |
| 2022 | 48,266 | $2.69M | |
| 2023 | 57,992 | $3.23M | |
| 2024incomplete | 46,265 | $2.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 29% | 16,989 | 11,836 | $3.32M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 25,294 | 22,483 | $2.56M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 16% | 11,817 | 10,410 | $1.84M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13% | 10,934 | 9,857 | $1.50M |
| 95117 | 8.1% | 104,117 | 55,366 | $934K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.7% | 6,424 | 5,781 | $427K |
| J2357 | Injection, omalizumab, 5 mg | 3.2% | 213 | 158 | $366K |
| 95115 | <1% | 12,571 | 7,124 | $103K | |
| 94375 | <1% | 3,710 | 3,289 | $95K | |
| 94726 | <1% | 1,314 | 1,176 | $53K | |
| 99205 | Prolong outpt/office vis | <1% | 245 | 211 | $48K |
| 94010 | <1% | 1,729 | 1,589 | $44K |
20 more codes
| 94729 | <1% | 919 | $39K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 528 | $37K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 218 | $37K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 900 | $14K |
| 94760 | <1% | 5,390 | $14K | |
| 95012 | <1% | 970 | $12K | |
| 96401 | <1% | 166 | $10K | |
| A4617 | Mouth piece | <1% | 4,235 | $6K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 3,425 | $6K |
| 95024 | <1% | 82 | $5K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 339 | $5K |
| 96160 | <1% | 1,476 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $777.49 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 15 | $312.08 |
| 94060 | <1% | 17 | $97.16 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 13 | $76.17 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 45 | $27.12 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 53 | $5.02 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 13 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 3,369 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNUTSON, TAYLOR (CHIEF OF STAFF)
| Provider | Location | Paid |
|---|---|---|
| Alabama Asthma, Allergy & Immunology Center, P.C. | Huntsville, AL | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.